{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:13:18Z","timestamp":1792206798159,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jinf.2023.08.009","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T17:05:26Z","timestamp":1695920726000},"page":"506-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3005-4523","authenticated-orcid":false,"given":"Michela","family":"Antonelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7023-7108","authenticated-orcid":false,"given":"Rose S.","family":"Penfold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liane Dos Santos","family":"Canas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Sudre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Rjoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7773-8140","authenticated-orcid":false,"given":"Erika","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Kerfoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2259-1556","authenticated-orcid":false,"given":"Nathan","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Capdevila","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Polidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Modat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Spector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5694-5340","authenticated-orcid":false,"given":"Sebastien","family":"Ourselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Steves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2023.08.009_bib1","unstructured":"Department of Health and Social Care. JCVI statement on the COVID-19 vaccination programme for 2023: 8 november 2022; 2023. [Updated 27 january 2023.; cited 2023 April 19]. Available from: https:\/\/www.gov.uk\/government\/publications\/covid-19-vaccination-programme-for-2023-jcvi-interim-advice-8-november-2022\/jcvi-statement-on-the-covid-19-vaccination-programme-for-2023-8-november-2022."},{"key":"10.1016\/j.jinf.2023.08.009_bib2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80428","article-title":"Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies","volume":"12","author":"Cheetham","year":"2023","journal-title":"elife"},{"key":"10.1016\/j.jinf.2023.08.009_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1038712","article-title":"Comprehensive assessment of SARS-CoV-2 antibodies against various antigenic epitopes after naive COVID-19 infection and vaccination (BNT162b2 or ChAdOx1 nCoV-19)","volume":"13","author":"Lee","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jinf.2023.08.009_bib4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41591-022-01704-7","article-title":"Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination","volume":"28","author":"Cheng","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2023.08.009_bib5","article-title":"Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong","volume":"32","author":"Zhou","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"issue":"3","key":"10.1016\/j.jinf.2023.08.009_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-021-01676-0","article-title":"mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant","volume":"28","author":"Gruell","year":"2022","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.jinf.2023.08.009_bib7","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3201\/eid2805.220141","article-title":"Effectiveness of BNT162b2 vaccine booster against SARS-CoV-2 infection and breakthrough complications, Israel","volume":"28","author":"Glatman-Freedman","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2023.08.009_bib8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41591-022-01699-1","article-title":"Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England","volume":"28","author":"Andrews","year":"2022","journal-title":"Nat Med"},{"issue":"5152","key":"10.1016\/j.jinf.2023.08.009_bib9","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.15585\/mmwr.mm715152e1","article-title":"Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19-associated emergency department or urgent care encounters and hospitalizations among immunocompetent adults - VISION Network, Nine States, September-November 2022","volume":"71","author":"Tenforde","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"14","key":"10.1016\/j.jinf.2023.08.009_bib10","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.2022.17985","article-title":"Incidence of Severe COVID-19 illness following vaccination and booster with BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines","volume":"328","author":"Kelly","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jinf.2023.08.009_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","article-title":"Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study","volume":"22","author":"Antonelli","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2023.08.009_bib12","article-title":"Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records","volume":"378","author":"Horne","year":"2022","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jinf.2023.08.009_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.54777","article-title":"Estimation of vaccine effectiveness of CoronaVac and BNT162b2 against severe outcomes over time among patients with SARS-CoV-2 Omicron","volume":"6","author":"Wei","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"16","key":"10.1016\/j.jinf.2023.08.009_bib14","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jinf.2023.08.009_bib15","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1473-3099(22)00146-3","article-title":"COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study","volume":"22","author":"Menni","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2023.08.009_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.2598","article-title":"Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods","volume":"6","author":"Link-Gelles","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jinf.2023.08.009_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004156","article-title":"Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: a test-negative design case-control study","volume":"20","author":"Cerqueira-Silva","year":"2023","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2023.08.009_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.puhe.2023.02.015","article-title":"COVID-19 vaccines effectiveness against symptomatic disease and severe outcomes, 2021-2022: a test-negative case-control study","volume":"218","author":"Brazete","year":"2023","journal-title":"Public Health"},{"issue":"1","key":"10.1016\/j.jinf.2023.08.009_bib19","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1038\/s41467-022-30884-6","article-title":"Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine","volume":"13","author":"Patalon","year":"2022","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.jinf.2023.08.009_bib20","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s41591-020-0916-2","article-title":"Real-time tracking of self-reported symptoms to predict potential COVID-19","volume":"26","author":"Menni","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.jinf.2023.08.009_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1027\/1016-9040.13.3.180","article-title":"A Euclidean distance-based matching procedure for nonrandomized comparison studies","volume":"13","author":"Spiel","year":"2008","journal-title":"Eur Psychol"},{"key":"10.1016\/j.jinf.2023.08.009_bib22","unstructured":"Centers for Disease Control and Prevention. Symptoms of COVID-19 Updated Oct 26, 2022. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html."},{"key":"10.1016\/j.jinf.2023.08.009_bib23","article-title":"Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors","volume":"12","author":"Cheetham","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.jinf.2023.08.009_bib24","article-title":"Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study","volume":"379","author":"Ferdinands","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2023.08.009_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41597-021-01071-x","article-title":"Accessible data curation and analytics for international-scale citizen science datasets","volume":"8","author":"Murray","year":"2021","journal-title":"Sci Data"},{"issue":"1","key":"10.1016\/j.jinf.2023.08.009_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ageing\/afaa223","article-title":"Probable delirium is a presenting symptom of COVID-19 in frail, older adults: a cohort study of 322 hospitalised and 535 community-based older adults","volume":"50","author":"Zazzara","year":"2021","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.jinf.2023.08.009_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.archger.2007.06.004","article-title":"PRISMA-7: a case-finding tool to identify older adults with moderate to severe disabilities","volume":"47","author":"Ra\u00eeche","year":"2008","journal-title":"Arch Gerontol Geriatr"},{"issue":"15","key":"10.1016\/j.jinf.2023.08.009_bib28","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.2022.18550","article-title":"Association of mRNA vaccination with clinical and virologic features of COVID-19 among US essential and frontline workers","volume":"328","author":"Thompson","year":"2022","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jinf.2023.08.009_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd4177","article-title":"Symptom clusters in COVID-19: a potential clinical prediction tool from the COVID Symptom Study app","volume":"7","author":"Sudre","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jinf.2023.08.009_bib30","article-title":"Post-acute symptoms four months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study","author":"Spiliopoulos","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.jinf.2023.08.009_bib31","first-page":"2023","article-title":"Associations of COVID-19 Symptoms with Omicron Subvariants BA.2 and BA.5, host status, and clinical outcomes: a registry-based observational study in Sapporo, Japan","volume":"7","author":"Nakakubo","year":"2023","journal-title":"medRxiv"},{"issue":"9","key":"10.1016\/j.jinf.2023.08.009_bib32","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/cea.12780","article-title":"Pathogenesis of rhinitis","volume":"46","author":"Eifan","year":"2016","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.jinf.2023.08.009_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12879-022-07418-y","article-title":"SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis","volume":"22","author":"Ssentongo","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"10328","key":"10.1016\/j.jinf.2023.08.009_bib34","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"issue":"10286","key":"10.1016\/j.jinf.2023.08.009_bib35","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(21)00847-3","article-title":"UK guidelines for managing long-term effects of COVID-19","volume":"397","author":"Shah","year":"2021","journal-title":"Lancet"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445323004619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445323004619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:37:28Z","timestamp":1759009048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445323004619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0163445323004619"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2023.08.009","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2023.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}